IFNGR2, the receptor for interferon-gamma, plays a dual role in immune response modulation and is associated with the polarization of microglia and macrophages within the glioma microenvironment, influencing immunogenicity and the efficacy of immunotherapies [35,36]. The gene discussed is IFNG; the disease is central nervous system cancer.